Skip to main content

Riley Antony A's Form 4 filing

Forte Biosciences, Inc. (FBRX) · filed Jan 2, 2026

Accession no.
0001339375-26-000002
Filed
Jan 2, 2026
Trade date
Dec 30, 2025-Jan 1, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $254.9K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Riley Antony ACIK 0001339375Officer (CHIEF FINANCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 30, 2025Common StockPPurchaseAcquired+9,680$26.33+$254,874.441,520Direct
Jan 1, 2026Common StockMOption exerciseAcquired+375$0.00$041,895Direct
Jan 1, 2026Common StockFTax withholdingDisposed−154$27.27−$4,199.5841,741Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 1, 2026Common StockMOption exerciseDisposed−375$0.00$01,500Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)